Praveen Tyle - Jan 5, 2023 Form 4/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/Praveen Tyle, Ph.D.
Stock symbol
SKYE
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/9/2023, 10:28 AM
Date Of Original Report
Jan 6, 2023
Previous filing
Feb 3, 2022
Next filing
Mar 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Stock Option (Right to Buy) Award $0 +250K $0.00 250K Jan 5, 2023 Common Stock 250K $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 (the "Grant Date") and the options will vest in equal monthly installments over the one year period from December 8, 2022.